CRVS Chart
- 52-Week Range: $1.03 - $8.53
- Market Capitalization: $48.42M
- Short Percentage: 0%
- Target Price: $6.38
- Shares Outstanding: 46.55M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CRVS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Corvus Pharmaceuticals to Host R&D Symposium on May 10, 2022 in New YorkGlobeNewsWire | April 26th
- Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 10th
- Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire | November 1st
- Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818PRNewsWire | October 25th
- Hot Penny Stocks to Buy This Week? 3 For Your October WatchlistPennyStocks | October 11th
Company Info
Website: https://www.corvuspharma.com
Address: 863 Mitten Road, Burlingame, CA, United States, 94010
Sector: Healthcare
Industry: Biotechnology
Full time employees: 28
Address: 863 Mitten Road, Burlingame, CA, United States, 94010
Sector: Healthcare
Industry: Biotechnology
Full time employees: 28
$CRVS bull trap confirmed
$CRVS do what the markets tells you to do not the other way around
$CRVS Who else bought the dip on Friday?
$CRVS Dip buyers are going to get wrecked
$CRVS we need one good push to moon this.
$CRVS buy and hold and get rewarded
$CRVS getting this mare ready to run today
$CRVS now is the time to slap that ask!!!
$CRVS I mean ... head and shoulders .....
$CRVS buy SHARES